Key facts
- This page summarizes KLEINER PERKINS CAUFIELD & BYERS XIII, LLC's Form 4 filing for Progyny, Inc. (PGNY).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 22 Jun 2021, 19:43.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Other
Other
Other
Additional SEC filing notes
Section 16 status
KLEINER PERKINS CAUFIELD & BYERS XIII, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII") without consideration to its members (the "Fund Distribution"). Excludes 101,100 shares of Common Stock for which a change in the form of beneficial ownership for individuals and entities associated with Kleiner Perkins Caufield & Byers occurred.
Footnote F2
The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 535,248 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.
Footnote F3
Represents a change in the form of ownership as a result of the receipt by XIII Associates of shares in the Fund Distribution.
Footnote F4
Consists of 467,415 shares of Common Stock of the Issuer held by XIII Associates.
Footnote F5
Represents a pro-rata in-kind distribution of Common Stock of the Issuer by XIII Associates without consideration to its members.
Footnote F6
Consists of 29,494 shares of Common Stock of the Issuer held by XIII Associates.